Evidence and implications of pre ‐existing humoral cross‐reactive immunity to SARS‐CoV‐2
ConclusionAlthough the clinical relevance of the observed reactivity can only be speculated and needs to be investigated, the implication of this finding for coronavirus disease 2019 seroepidemiological survey and vaccines' clinical trials is critical.
Source: Immunity, Inflammation and Disease - Category: Allergy & Immunology Authors: Amandine Mveang Nzoghe,
Paulin N. Essone,
Marielle Leboueny,
Anicet Christel Maloupazoa Siawaya,
Eliode Cyrien Bongho,
Ofilia Mvoundza Ndjindji,
Rotimi Myrabelle Avome Houechenou,
Selidji Todagbe Agnandji,
Joel Fleury Djoba Siawaya Tags: ORIGINAL RESEARCH Source Type: research
More News: Allergy & Immunology | Clinical Trials | Coronavirus | COVID-19 | Pandemics | Respiratory Medicine | SARS | Vaccines